NCT04066257View on ClinicalTrials.gov

Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 17, 2019

Primary Completion Date

February 22, 2019

Study Completion Date

April 25, 2019

Conditions
Healthy
Interventions
DRUG

Tegoprazan

Tegoprazan 50 mg tablet

DRUG

Metronidazole

Metronidazole 250 mg tablet

DRUG

Tetracycline

Tetracycline hydrochloride 250 mg capsule

DRUG

Bismuth

Tripotassium bismuth dicitrate 300 mg tablet

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY